What happened is the potential value trapped within ILA has been (partially) released. ILA should not have been trading at 7-8c post the acquisition of Galidisivir and heading into the Phase 2a/b for ISLA-101, but it was because the market knew they company needed $3.5m and had no realistic way of raising that amount of capital. The raise has allowed this trapped value to be released benefiting all shareholders.
The new director’s “sign-on bonus” didn’t come from existing shareholders (well technically it did as all the investors were already shareholders), but from the investors. We were all scaled back to make room for Chris’ allocation.
Ann: Investor webinar, page-68
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ILA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $18.70M | |||
| Open | High | Low | Value | Volume |
| 12.0¢ | 13.5¢ | 12.0¢ | $80.72K | 671.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 98882 | 11.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.0¢ | 80000 | 1 |
View Market Depth
| Last trade - 15.45pm 08/11/2024 (20 minute delay) ? |
| ILA (ASX) Chart |